Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr Endocrinol Metab ; 33(10): 1321-1333, 2020 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-32892177

RESUMO

Objectives The aim of our study is to systematically describe the genotypic and phenotypic spectrum of Glycogen storage disease type VI (GSD VI), especially in Chinses population.  Methods We retrospectively analyzed ten Chinese children diagnosed as having GSD VI confirmed by next generation sequencing in Children's Hospital of Fudan University and Jinshan Hospital of Fudan University. We described the genotypic and phenotypic spectrum of GSD VI through the clinical and genetic data we collected. Moreover, we conducted a literature review, and we compared the genotypic and phenotypic spectrum of GSD VI between Chinese population and non Chinese population.  Results For the first time, we found that four Chinese patients showed cirrhosis in liver biopsy characterized by the formation of regenerative nodules. In addition, c.772+1G>A and c.1900G>C, p.(Asp634His) were recurrent in three Chinese families and four European families respectively indicating that the genotypic spectrum of PYGL gene may vary among the population. Furthermore, we identified seven novel variants in PYGL gene.  Conclusions Our study enriched the genotypic and phenotypic spectrum of GSD VI, and provided a new clue for management of GSD VI.


Assuntos
Povo Asiático/genética , Glicogênio Fosforilase Hepática/genética , Doença de Depósito de Glicogênio Tipo VI/complicações , Cirrose Hepática/patologia , Mutação , Biomarcadores/análise , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Seguimentos , Genótipo , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Lactente , Cirrose Hepática/etiologia , Cirrose Hepática/metabolismo , Masculino , Prognóstico , Estudos Retrospectivos
2.
Curr Opin Clin Nutr Metab Care ; 18(4): 415-21, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26001652

RESUMO

PURPOSE OF REVIEW: Glycogen storage disorders (GSDs) are inborn errors of metabolism with abnormal storage or utilization of glycogen. The present review focuses on recent advances in hepatic GSD types I, III and VI/IX, with emphasis on clinical aspects and treatment. RECENT FINDINGS: Evidence accumulates that poor metabolic control is a risk factor for the development of long-term complications, such as liver adenomas, low bone density/osteoporosis, and kidney disease in GSD I. However, mechanisms leading to these complications remain poorly understood and are being investigated. Molecular causes underlying neutropenia and neutrophil dysfunction in GSD I have been elucidated. Case series provide new insights into the natural course and outcome of GSD types VI and IX. For GSD III, a high protein/fat diet has been reported to improve (cardio)myopathy, but the beneficial effect of this dietary concept on muscle and liver disease manifestations needs to be further established in prospective studies. SUMMARY: Although further knowledge has been gained regarding pathophysiology, disease course, treatment, and complications of hepatic GSDs, more controlled prospective studies are needed to assess effects of different dietary and medical treatment options on long-term outcome and quality of life.


Assuntos
Doença de Depósito de Glicogênio Tipo III/fisiopatologia , Doença de Depósito de Glicogênio Tipo I/fisiopatologia , Doença de Depósito de Glicogênio Tipo VI/fisiopatologia , Fígado/fisiopatologia , Animais , Cardiomiopatias/complicações , Cardiomiopatias/dietoterapia , Cardiomiopatias/fisiopatologia , Dieta com Restrição de Carboidratos , Dieta Hiperlipídica , Carboidratos da Dieta/administração & dosagem , Gorduras na Dieta/administração & dosagem , Proteínas Alimentares/administração & dosagem , Modelos Animais de Doenças , Glicogênio/metabolismo , Doença de Depósito de Glicogênio Tipo I/complicações , Doença de Depósito de Glicogênio Tipo I/diagnóstico , Doença de Depósito de Glicogênio Tipo I/dietoterapia , Doença de Depósito de Glicogênio Tipo III/complicações , Doença de Depósito de Glicogênio Tipo III/diagnóstico , Doença de Depósito de Glicogênio Tipo III/dietoterapia , Doença de Depósito de Glicogênio Tipo VI/complicações , Doença de Depósito de Glicogênio Tipo VI/diagnóstico , Doença de Depósito de Glicogênio Tipo VI/dietoterapia , Humanos , Cirrose Hepática/complicações , Cirrose Hepática/dietoterapia , Cirrose Hepática/fisiopatologia
3.
Mol Genet Metab ; 113(3): 171-6, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25266922

RESUMO

OBJECTIVES: Glycogen storage disease (GSD) types VI and IX are caused by phosphorylase system deficiencies. To evaluate the natural history and long-term treatment outcome of the patients with GSD-VI and -IX, we performed an observational retrospective case study of 21 patients with confirmed diagnosis of GSD-VI or -IX. METHODS: All patients with GSD-VI or -IX, diagnosed at The Hospital for Sick Children, were included. Electronic and paper charts were reviewed for clinical features, biochemical investigations, molecular genetic testing, diagnostic imaging, long-term outcome and treatment by two independent research team members. All information was entered into an Excel database. RESULTS: We report on the natural history and treatment outcomes of the 21 patients with GSD-VI and -IX and 16 novel pathogenic mutations in the PHKA2, PHKB, PHKG2 and PYGL genes. We report for the first time likely liver adenoma on liver ultrasound and liver fibrosis on liver biopsy specimens in patients with GSD-VI and mild cardiomyopathy on echocardiography in patients with GSD-VI and -IXb. CONCLUSION: We recommend close monitoring in all patients with GSD-VI and -IX for the long-term liver and cardiac complications. There is a need for future studies if uncooked cornstarch and high protein diet would be able to prevent long-term complications of GSD-VI and -IX.


Assuntos
Doença de Depósito de Glicogênio Tipo VI/genética , Adolescente , Canadá , Criança , Pré-Escolar , Análise Mutacional de DNA , Feminino , Doença de Depósito de Glicogênio/complicações , Doença de Depósito de Glicogênio/genética , Doença de Depósito de Glicogênio/terapia , Doença de Depósito de Glicogênio Tipo VI/complicações , Doença de Depósito de Glicogênio Tipo VI/terapia , Humanos , Cirrose Hepática/genética , Masculino , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA